Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
27 hedge funds and large institutions have $1.03M invested in Coeptis Therapeutics Warrants in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
42% more funds holding
Funds holding: 19 → 27 (+8)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
10% less capital invested
Capital invested by funds: $1.15M → $1.03M (-$118K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$29.2K |
| 2 |
HF
HRT Financial
New York
|
+$7.52K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.57K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$2.61K |
| 5 |
Walleye Capital
New York
|
+$1.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$49K |
| 2 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$4K |
| 3 |
VF
Virtu Financial
New York
|
-$2K |
| 4 |
SM
Skaana Management
Brooklyn,
New York
|
-$376 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ICMH
26
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$4K | -54,649 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$2K | -18,566 | Closed |
|
|
CS
28
Clear Street
New York
| – | +$105 | +1,400 | New |
|
29
UBS Group
Zurich,
Switzerland
| – | +$774 | +10,305 | New |
|
|
OMC
30
Old Mission Capital
Chicago,
Illinois
| – | +$860 | +11,458 | New |
|
COEPW Hedge Fund Activity: Q2 2022 in Review
27 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2022, worth a combined $1.03M — down 10% from $1.15M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new COEPW positions and 3 closed out — a net gain of 8 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Meteora Capital, opening a new position worth an estimated $29.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $49K sold.
- 27 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2022, up from 19 in Q1 2022.
- Funds reported $1.03M of Coeptis Therapeutics Warrants stock for Q2 2022, down 10% quarter-over-quarter.
- 11 funds opened new Coeptis Therapeutics Warrants positions in Q2 2022 and 3 closed out, a net change of +8 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q2 2022 was Meteora Capital, an estimated $29.2K added.
- The largest Coeptis Therapeutics Warrants seller in Q2 2022 was Citadel Advisors, an estimated $49K sold.
Based on aggregated 13F filings for Q2 2022.